CHARLES M. BAUM

Insider Reports History

Location
San Diego, CA
Signature
/s/ Adam D. Levy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CHARLES M. BAUM:

Company Role Class Num Shares Value Price $ Report Date Ownership
Poseida Therapeutics, Inc. Director Common Stock 0 $0 $9.60 08 Jan 2025 Direct
PMV Pharmaceuticals, Inc. Director Stock Option (right to buy) 33,500 05 Jun 2025 Direct
Acrivon Therapeutics, Inc. Director Stock Option (Right to Buy) 20,275 13 Jun 2025 Direct
Mirati Therapeutics, Inc. Founder, President, and CEO, Director Common Stock 0 $59.02 23 Jan 2024 Direct
Mirati Therapeutics, Inc. Founder, President, and CEO, Director Option to Purchase Common Stock 0 23 Jan 2024 Direct
Poseida Therapeutics, Inc. Director Stock Option (Right to Buy) 0 08 Jan 2025 Direct

Insider Reports Filed by CHARLES M. BAUM

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRV Acrivon Therapeutics, Inc. 13 Jun 2025 1 $0 4 Director 17 Jun 2025, 17:21
PMVP PMV Pharmaceuticals, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:20
PSTX Poseida Therapeutics, Inc. 08 Jan 2025 4 $0 4 Director 08 Jan 2025, 14:12
ACRV Acrivon Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director 24 Jun 2024, 17:26
PSTX Poseida Therapeutics, Inc. 17 Jun 2024 2 $0 4 Director 18 Jun 2024, 16:13
PMVP PMV Pharmaceuticals, Inc. 06 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:15
MRTX Mirati Therapeutics, Inc. 23 Jan 2024 11 $0 4 Founder, President, and CEO, Director 23 Jan 2024, 20:37
MRTX Mirati Therapeutics, Inc. 29 Dec 2023 1 +$1,199,969 4 Interim CEO, Director 03 Jan 2024, 17:52
MRTX Mirati Therapeutics, Inc. 09 Aug 2023 1 +$1,999,998 4 Interim CEO, Director 10 Aug 2023, 16:24
ACRV Acrivon Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 28 Jun 2023, 17:06
ACRV Acrivon Therapeutics, Inc. 22 Jun 2023 0 $0 3 Director 28 Jun 2023, 16:58
PSTX Poseida Therapeutics, Inc. 15 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:08
PMVP PMV Pharmaceuticals, Inc. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 17:10
MRTX Mirati Therapeutics, Inc. 20 Jan 2023 2 $0 4 President,Founder,Head of R&D, Director 24 Jan 2023, 15:20
MRTX Mirati Therapeutics, Inc. 04 Jan 2023 1 -$169,997 4 President,Founder,Head of R&D, Director 05 Jan 2023, 16:13
MRTX Mirati Therapeutics, Inc. 19 Dec 2022 2 -$367,469 4 President,Founder,Head of R&D, Director 21 Dec 2022, 20:21
MRTX Mirati Therapeutics, Inc. 28 Nov 2022 3 -$5,719,853 4 President,Founder,Head of R&D, Director 28 Nov 2022, 18:01
PSTX Poseida Therapeutics, Inc. 16 Jun 2022 2 $0 4 Director 16 Jun 2022, 20:59
PMVP PMV Pharmaceuticals, Inc. 02 Jun 2022 1 $0 4 Director 06 Jun 2022, 17:34
PSTX Poseida Therapeutics, Inc. 16 May 2022 0 $0 3 Director 18 May 2022, 16:30
MRTX Mirati Therapeutics, Inc. 14 Jan 2022 5 -$203,272 4 President,Founder,Head of R&D, Director 18 Jan 2022, 19:32
MRTX Mirati Therapeutics, Inc. 04 Jan 2022 2 -$607,855 4 President,Founder,Head of R&D, Director 06 Jan 2022, 15:51
MRTX Mirati Therapeutics, Inc. 16 Dec 2021 1 $0 4 President & CEO, Director 17 Dec 2021, 18:10
MRTX Mirati Therapeutics, Inc. 03 Dec 2021 9 -$5,886,926 4 President & Head of R&D, Director 03 Dec 2021, 19:09
MRTX Mirati Therapeutics, Inc. 18 Jun 2021 6 -$6,278,633 4 President & CEO, Director 21 Jun 2021, 17:12
PMVP PMV Pharmaceuticals, Inc. 02 Jun 2021 1 $0 4 Director 09 Jun 2021, 17:28